EuBiologics signs ₩10.5bn oral cholera vaccine supply contract with UNICEF

EuBiologics · KOSDAQ · 206650 · Oct 26, 2026 · Supply contracts

EuBiologics filed a supply contract to supply its oral cholera vaccine (Euvichol-S) to UNICEF, with a contract amount of ₩10.5bn. The contract period runs from Oct 23, 2026 to Jan 31, 2027, and the amount is 7.0% of revenue as reported.

Key facts

Contract nameOral cholera vaccine (Euvichol-S) supply
CounterpartyUNICEF
Contract amount₩10.5bn
% of revenue (as reported)7.0%
Period startOct 23, 2026
Period endJan 31, 2027

Comparison

Amount as % of FY2025 revenue (calculated)7.0%
Revenue 2025₩149.2bn
Revenue 2024₩96.0bn
Revenue 2023₩69.4bn

Context

In the 12 months before this filing, EuBiologics filed 5 supply contracts totaling ₩69.1bn, all with UNICEF.

Key metrics

Supply contracts

Supply contracts, last 12 months₩79.6bn As of Oct 26, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Supply contracts vs prior-year revenue53.3% As of Oct 26, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)